Home › Mesothelioma › Texas › Houston
Pag-aaral pangklinika para sa Mesothelioma sa Houston, TX
Isang pag-aaral para sa Mesothelioma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Houston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
SW-682 in Advanced Solid Tumors
Nagre-recruitPhase 1
- U.T. MD Anderson Cancer Center, Houston
Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
- Baylor St Lukes, Houston
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Nagre-recruitPhase 1
- MD Anderson, Houston
- NEXT Oncology Houston, Houston
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- The University of Texas MD Anderson Cancer Center, Houston
TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma
Nagre-recruitPhase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Nagre-recruitPhase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Nagre-recruitPhase 1
- MDACC, Houston
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Nagre-recruitPhase 1/2
- MD Anderson Cancer Center, Houston
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
Nagre-recruitPhase 1
- MD Anderson Cancer Center, Houston
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Nagre-recruitPhase 1/2
- MD Anderson Cancer Center, Houston
A Study of VET3-TGI in Patients With Solid Tumors
Nagre-recruitPhase 1
- University of Texas MD Anderson Cancer Center, Houston
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- MD Anderson Cancer Center, Houston
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Nagre-recruitPhase 1/2
- The University of Texas MD Anderson Cancer Center (site 127), Houston
A Study of NX-1607 in Adults With Advanced Malignancies
Nagre-recruitPhase 1
- MD Anderson Cancer Center, Houston
A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors
Nagre-recruitPhase 1
- MD Anderson Cancer Center, Houston
Pag-aaral para sa Mesothelioma sa ibang lungsod
- New York City, NY10 pag-aaral
- Washington, DC9 pag-aaral
- Chicago, IL9 pag-aaral
- Boston, MA8 pag-aaral
- Nashville, TN8 pag-aaral
- Los Angeles, CA6 pag-aaral
- Arlington, VA6 pag-aaral
- Pittsburgh, PA6 pag-aaral
- Philadelphia, PA6 pag-aaral
- Seattle, WA6 pag-aaral
- Edison, NJ5 pag-aaral
- Columbus, OH5 pag-aaral
Iba pang pag-aaral sa Houston
- Non-Small Cell Lung Cancer145 pag-aaral
- Kanser sa Suso126 pag-aaral
- Kanser (lahat ng uri)121 pag-aaral
- Metastatic Cancer104 pag-aaral
- Colorectal Cancer102 pag-aaral
- Kanser sa Ovary89 pag-aaral
- Acute Myeloid Leukemia85 pag-aaral
- Kanser sa Baga78 pag-aaral
- Kanser sa Prostate76 pag-aaral
- Kanser ng Endometrium68 pag-aaral
- Kanser sa Pancreas61 pag-aaral
- Melanoma59 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.